Nisina is commonly known as alogliptin benzoate, which is mainly used for the treatment of type 2 diabetes mellitus, but it is important to note that it is contraindicated in type 1 diabetes mellitus and ketoacidosis. Alogliptin benzoate is mainly used for type 2 diabetes and is often used as an adjunctive therapeutic agent in the process of controlling blood sugar with diet and exercise. The drug can be used in combination with drugs such as metformin hydrochloride to enhance the effect of blood sugar control. If adverse reactions such as pancreatitis, hypoglycemia, or urticaria occur, it is recommended to stop using the drug and consult a doctor promptly. However, it should be noted that the efficacy of Alogliptin for type 1 diabetes, diabetic ketoacidosis and other diseases is not clear, so Alogliptin is not used in the treatment of this disease. In addition it is contraindicated in cases of severe allergy to the components of the drug. The use of the drug is not recommended during pregnancy and lactation. Alogliptin benzoate needs to be used under the guidance of a clinician, unauthorized use is prohibited; the appearance of diabetes, it is recommended to go to the hospital in time.